JPS5473113A - Preparation of substance having immune function controlling activity - Google Patents
Preparation of substance having immune function controlling activityInfo
- Publication number
- JPS5473113A JPS5473113A JP13973377A JP13973377A JPS5473113A JP S5473113 A JPS5473113 A JP S5473113A JP 13973377 A JP13973377 A JP 13973377A JP 13973377 A JP13973377 A JP 13973377A JP S5473113 A JPS5473113 A JP S5473113A
- Authority
- JP
- Japan
- Prior art keywords
- solvent
- water
- substance
- immune function
- pholiota
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036737 immune function Effects 0.000 title abstract 3
- 239000000126 substance Substances 0.000 title abstract 3
- 230000001276 controlling effect Effects 0.000 title abstract 2
- 239000002904 solvent Substances 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 241000722337 Pholiota Species 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 238000000605 extraction Methods 0.000 abstract 2
- 241000221198 Basidiomycota Species 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 241000287319 Pholiota terrestris Species 0.000 abstract 1
- 230000005856 abnormality Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 235000011869 dried fruits Nutrition 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 230000035931 haemagglutination Effects 0.000 abstract 1
- 239000012046 mixed solvent Substances 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 239000012266 salt solution Substances 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
PURPOSE: To prepare a substance having strong lymphocyte-rejuvenating activity, free from haemagglutination effect, low toxic, and useful for the remedy of diseases caused by abnormality of immune function, by extracting fungi belonging to Strophariaceae Pholiota.
CONSTITUTION: Fruit bodies of Basidiomycetes belonging to Strophariaceae Pholiota, e.g. pholiota terrestris, are washed with water, physiological salt solution, etc., and extracted with a solvent. The solvent is water or a water-miscible organic solvent, e.g. lower alcohol, acetone, etc, and usually a mixed solvent of water and a lower alcohol. The amount of the solvent is usually 3W15 times, pref. 5W10 times the weight of the dried fruit body. The extraction is carried out at room temperature (15W25°C) for several hours to several weeks. After the extraction, the fruit bodies are separated from the extract by filtration or centrifugal separation, and the extract is concentrated to obtain the substance having immune function controlling activity.
COPYRIGHT: (C)1979,JPO&Japio
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13973377A JPS5473113A (en) | 1977-11-21 | 1977-11-21 | Preparation of substance having immune function controlling activity |
| PCT/JP1978/000031 WO1979000304A1 (en) | 1977-11-18 | 1978-11-18 | Process for producing a substance with immune function control effect |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13973377A JPS5473113A (en) | 1977-11-21 | 1977-11-21 | Preparation of substance having immune function controlling activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5473113A true JPS5473113A (en) | 1979-06-12 |
Family
ID=15252106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13973377A Pending JPS5473113A (en) | 1977-11-18 | 1977-11-21 | Preparation of substance having immune function controlling activity |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5473113A (en) |
-
1977
- 1977-11-21 JP JP13973377A patent/JPS5473113A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS55105677A (en) | Production of catechins | |
| MA20754A1 (en) | DIETETIC PRODUCT WITH DEPURATIVE AND ANTI-DIARRHEIC ACTIVITY AND PREPARATION METHOD THEREOF | |
| Julien et al. | Extracts of the ivy plant, Hedera helix, and their anthelminthic activity on liver flukes | |
| JPS6447718A (en) | Diabetic remedy | |
| JPS57206384A (en) | Cultivating method of cell | |
| JPS5473113A (en) | Preparation of substance having immune function controlling activity | |
| JPS55111791A (en) | Antitumor substance | |
| JPS5473112A (en) | Preparation of substance having immune function controlling activity | |
| JPS5738794A (en) | Antitumor substance | |
| IE39246B1 (en) | Process for preparing a purified extract of quillata bark | |
| JPS6447719A (en) | Hyperlipemia alleviating drug | |
| Ajani et al. | Antioxidant capacity of fractionated extract and structural elucidation of isolated compounds from leaf extract of Hydrocotyl bonariensis Comm. Exlam | |
| JPS5695182A (en) | Production of catechin | |
| SU1733001A1 (en) | Method for preparation of remedy, showing antiinflammatory and wound-healing action | |
| JP2535674B2 (en) | Hypoglycemic agent | |
| JPS5738723A (en) | Production of substance having antitumorigenic activity | |
| JPS5688793A (en) | Preparation of novel ascobate oxidase | |
| JPS53127808A (en) | Preparation of human albumin | |
| SU118265A1 (en) | Method of extracting concentrates of vitamins of group P from rosehip pulp | |
| SU133190A1 (en) | The method of obtaining podofillina | |
| JPS5655334A (en) | Dimeric tetrahydroanthracene compound | |
| JPS5736988A (en) | Preparation of substance having anti-tumor activity | |
| JPS5543044A (en) | Extraction of propionic acid derivative from panax notoginseng e.h. chen, and hemostatic agent and blood platelet increasing agent containing said derivative | |
| SU152276A1 (en) | Method of obtaining glyzirrhizic acid | |
| JPS5394015A (en) | Preparation of anti-tumor polysaccharide |